Jacob Vosberg, DO
Internal Medicine · San Antonio, TXNPI 1285213314
Payments from drug & device makers
Across 48 payments — averaging $20.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$147
- Pfizer$140
- Lilly USA, LLC$137
- AstraZeneca$100
- Boehringer Ingelheim$70
- Viiv Healthcare Company$49
- plus $319 from 12 others
What the payments were for
- Food & beverage$963100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 8 | $147 |
| Pfizer | 7 | $140 |
| Lilly USA, LLC | 8 | $137 |
| AstraZeneca | 5 | $100 |
| Boehringer Ingelheim | 3 | $70 |
| Viiv Healthcare Company | 2 | $49 |
| Dexcom, Inc. | 2 | $46 |
| Tactile Systems Technology Inc | 1 | $38 |
| Vertex | 1 | $35 |
| Exact Sciences | 2 | $31 |
| AbbVie | 1 | $31 |
| Amgen | 2 | $30 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Lundbeck LLC | 1 | $20 |
| Alk-abello, Inc | 1 | $20 |
| Insulet Corporation | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Bayer | 1 | $14 |
How this compares
$963 in reported general payments places this provider in the 65th percentile of 7,675 internal medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 47 | $617 |
| Lisinopril | 29 | $373 |
| Pantoprazole Sodium | 35 | $357 |
| Rosuvastatin Calcium | 12 | $326 |
| Amlodipine Besylate | 47 | $245 |
| Fluticasone Propionate | 12 | $203 |
| Chlorthalidone | 15 | $170 |
| Tamsulosin Hcl | 11 | $150 |
| Metoprolol Succinate | 11 | $145 |
| Metformin Hcl | 11 | $139 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $71 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in San Antonio
- Robert BassSan Antonio$25.6M
- Hernan SalazarSan Antonio$18.5M
- Dennis RuffSan Antonio$7.5M
- Cassandra KeySan Antonio$5.6M
- Jan BurgerHouston$47.3M
- Nitin JainHouston$33.2M
- Muhammad IrfanTomball$30.6M
- Aung NaingHouston$30.6M
- Preetesh JainHouston$19.5M
- Paolo StratiHouston$19.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.